JP2007512377A5 - - Google Patents

Download PDF

Info

Publication number
JP2007512377A5
JP2007512377A5 JP2006541731A JP2006541731A JP2007512377A5 JP 2007512377 A5 JP2007512377 A5 JP 2007512377A5 JP 2006541731 A JP2006541731 A JP 2006541731A JP 2006541731 A JP2006541731 A JP 2006541731A JP 2007512377 A5 JP2007512377 A5 JP 2007512377A5
Authority
JP
Japan
Prior art keywords
composition
matrix
vector
expression cassette
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006541731A
Other languages
English (en)
Japanese (ja)
Other versions
JP4842139B2 (ja
JP2007512377A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/039633 external-priority patent/WO2005051971A1/en
Publication of JP2007512377A publication Critical patent/JP2007512377A/ja
Publication of JP2007512377A5 publication Critical patent/JP2007512377A5/ja
Application granted granted Critical
Publication of JP4842139B2 publication Critical patent/JP4842139B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006541731A 2003-11-24 2004-11-23 皮膚瘢痕の縮小 Expired - Fee Related JP4842139B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US52499303P 2003-11-24 2003-11-24
US60/524,993 2003-11-24
PCT/US2004/039633 WO2005051971A1 (en) 2003-11-24 2004-11-23 Reduction of dermal scarring

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011160099A Division JP2011207912A (ja) 2003-11-24 2011-07-21 皮膚瘢痕の縮小

Publications (3)

Publication Number Publication Date
JP2007512377A JP2007512377A (ja) 2007-05-17
JP2007512377A5 true JP2007512377A5 (cg-RX-API-DMAC7.html) 2007-12-27
JP4842139B2 JP4842139B2 (ja) 2011-12-21

Family

ID=34632948

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006541731A Expired - Fee Related JP4842139B2 (ja) 2003-11-24 2004-11-23 皮膚瘢痕の縮小
JP2011160099A Withdrawn JP2011207912A (ja) 2003-11-24 2011-07-21 皮膚瘢痕の縮小

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011160099A Withdrawn JP2011207912A (ja) 2003-11-24 2011-07-21 皮膚瘢痕の縮小

Country Status (13)

Country Link
US (3) US7465442B2 (cg-RX-API-DMAC7.html)
EP (1) EP1692154A4 (cg-RX-API-DMAC7.html)
JP (2) JP4842139B2 (cg-RX-API-DMAC7.html)
KR (1) KR101167330B1 (cg-RX-API-DMAC7.html)
CN (2) CN101507822B (cg-RX-API-DMAC7.html)
AU (1) AU2004293474B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0416920A (cg-RX-API-DMAC7.html)
CA (1) CA2546287C (cg-RX-API-DMAC7.html)
IL (1) IL175603A (cg-RX-API-DMAC7.html)
NO (1) NO20062978L (cg-RX-API-DMAC7.html)
NZ (1) NZ546983A (cg-RX-API-DMAC7.html)
WO (1) WO2005051971A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200604147B (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004293474B2 (en) * 2003-11-24 2010-12-23 Canji, Inc. Reduction of dermal scarring
CA2781407A1 (en) 2008-01-14 2009-07-23 Michael P. Brenzel Apparatus and methods for fracture repair
EP2342340A1 (en) 2008-09-22 2011-07-13 Rxi Pharmaceuticals Corporation Rna interference in skin indications
WO2011088172A1 (en) 2010-01-15 2011-07-21 Brenzel Michael P Rotary-rigid orthopaedic rod
ES2733729T3 (es) 2010-01-20 2019-12-02 Conventus Orthopaedics Inc Aparato para el acceso a huesos y para la preparación de cavidades
CN107569279A (zh) 2010-03-08 2018-01-12 康文图斯整形外科公司 用于骨修复的装置及方法
CA2794189C (en) 2010-03-24 2022-01-11 Rxi Pharmaceuticals Corporation Rna interference in dermal and fibrotic indications
WO2015085113A1 (en) * 2013-12-04 2015-06-11 Rxi Pharmaceuticals Corporation Methods for treatment of wound healing utilizing chemically modified oligonucleotides
US10022132B2 (en) 2013-12-12 2018-07-17 Conventus Orthopaedics, Inc. Tissue displacement tools and methods
EP3188799B1 (en) 2014-09-05 2022-07-06 Phio Pharmaceuticals Corp. Methods for treating aging and skin disorders using nucleic acids targeting tyr or mmp1
US11311487B2 (en) 2016-04-14 2022-04-26 Trizell Ltd. Viral vector stabilization
JP7167059B2 (ja) 2017-04-19 2022-11-08 フィオ ファーマシューティカルズ コーポレーション 核酸化合物の局所送達
US10918426B2 (en) 2017-07-04 2021-02-16 Conventus Orthopaedics, Inc. Apparatus and methods for treatment of a bone

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4394370A (en) 1981-09-21 1983-07-19 Jefferies Steven R Bone graft material for osseous defects and method of making same
US4505266A (en) 1981-10-26 1985-03-19 Massachusetts Institute Of Technology Method of using a fibrous lattice
US4485097A (en) 1982-05-26 1984-11-27 Massachusetts Institute Of Technology Bone-equivalent and method for preparation thereof
JPH0662679B2 (ja) 1985-06-21 1994-08-17 新田ゼラチン株式会社 組織親和性コラ−ゲンとその製法
WO1992002247A1 (en) * 1990-08-01 1992-02-20 Chiron Ophthalmics, Inc. Method for treating corneal endothelial wounds
US5302706A (en) * 1991-12-16 1994-04-12 Baylor College Of Medicine Senescent cell derived inhibitors of DNA synthesis
US5596079A (en) * 1991-12-16 1997-01-21 Smith; James R. Mimetics of senescent cell derived inhibitors of DNA synthesis
US6372249B1 (en) * 1991-12-16 2002-04-16 Baylor College Of Medicine Senscent cell-derived inhibitors of DNA synthesis
DE69333043T2 (de) 1992-10-16 2004-05-06 Cold Spring Harbor Laboratory Umlagerung des cyclin komlexes und seine darauf bezogenen anwendungen
US6211334B1 (en) 1992-10-16 2001-04-03 Cold Spring Harbor Cell-cycle regulatory proteins, and uses related thereto
FR2702152B1 (fr) 1993-03-03 1995-05-24 Inst Nat Sante Rech Med Virus recombinants et leur utilisation en thérapie génique.
AU692794B2 (en) 1993-08-30 1998-06-18 Baylor College Of Medicine Senescent cell-derived inhibitors of DNA synthesis
TW442569B (en) * 1993-10-25 2001-06-23 Canji Inc Recombinant adenoviral vector
US6210939B1 (en) * 1993-10-25 2001-04-03 Canji, Inc. Recombinant adenoviral vector and methods of use
AU685627B2 (en) * 1994-03-18 1998-01-22 Myriad Genetics, Inc. Germline mutations in the MTS gene and method for detecting predisposition to cancer at the MTS gene
ATE283355T1 (de) 1994-05-24 2004-12-15 Baylor College Medicine Mimetika von aus alternden zellen abgeleitete hemmer der dna synthese
US5851806A (en) * 1994-06-10 1998-12-22 Genvec, Inc. Complementary adenoviral systems and cell lines
US5631156A (en) * 1994-06-21 1997-05-20 The University Of Michigan DNA encoding and 18 KD CDK6 inhibiting protein
CA2235810C (en) 1994-10-24 2010-02-09 Baylor College Of Medicine Senescent cell-derived inhibitors of dna synthesis
US5827702A (en) * 1994-10-31 1998-10-27 Genentech, Inc. Ocular gene therapy
GB9422175D0 (en) 1994-11-03 1994-12-21 Univ Dundee Indentification of the p21 waf1-pcna interaction site and therapeutic applications thereof
WO1996019244A1 (en) 1994-12-22 1996-06-27 The University Of North Carolina At Chapel Hill DNA ENCODING A 20 Kd CDK6 INHIBITING PROTEIN
US5837520A (en) * 1995-03-07 1998-11-17 Canji, Inc. Method of purification of viral vectors
US5856094A (en) 1995-05-12 1999-01-05 The Johns Hopkins University School Of Medicine Method of detection of neoplastic cells
US6027742A (en) * 1995-05-19 2000-02-22 Etex Corporation Bioresorbable ceramic composites
US5756283A (en) * 1995-06-05 1998-05-26 The Trustees Of The University Of Pennsylvania Method for improved production of recombinant adeno-associated viruses for gene therapy
CA2227193A1 (en) 1995-07-17 1997-02-06 Xiaomei Jin P16 expression constructs and their application in cancer therapy
GB9519275D0 (en) 1995-09-21 1995-11-22 Univ Dundee Substances and their therapeutic use
US5863904A (en) * 1995-09-26 1999-01-26 The University Of Michigan Methods for treating cancers and restenosis with P21
US5837511A (en) * 1995-10-02 1998-11-17 Cornell Research Foundation, Inc. Non-group C adenoviral vectors
WO1997026879A1 (en) * 1996-01-26 1997-07-31 The United States Of America, Represented By The Secretary, Department Of Health And Human Services, The National Institutes Of Health Hydroxylamine compositions for the prevention or retardation of cataracts
EP0954222A4 (en) 1996-04-10 2003-01-15 Univ Southern California GENE THERAPY FOR PROLIFERATIVE VITREORETINOPATHY
IT1285790B1 (it) * 1996-09-24 1998-06-24 Angeletti P Ist Richerche Bio Adenovirus difettivi ricombinanti che codificano per mutanti di interleuchina 6 umana (hil-6) con attivita' antagonista o
US6274614B1 (en) * 1997-02-11 2001-08-14 Qlt Inc. Methods, compositions and articles for reducing or preventing the effects of inflammation
JPH11205102A (ja) * 1998-01-13 1999-07-30 Mitsubishi Electric Corp 遅延同期回路
US6489305B1 (en) * 1998-05-08 2002-12-03 Canji, Inc. Methods and compositions for the treatment of ocular diseases
US6395029B1 (en) * 1999-01-19 2002-05-28 The Children's Hospital Of Philadelphia Sustained delivery of polyionic bioactive agents
AU6919300A (en) * 1999-08-20 2001-03-19 University Of Pittsburgh Methods for in vivo gene delivery to sites of cartilage damage
US6579522B1 (en) * 2000-06-27 2003-06-17 Genvec, Inc. Replication deficient adenoviral TNF vector
US6667173B2 (en) * 2000-12-01 2003-12-23 The Schepens Eye Research Institute Nucleic acids encoding platelet derived growth factor-alpha receptors
AU2004293474B2 (en) * 2003-11-24 2010-12-23 Canji, Inc. Reduction of dermal scarring
WO2006042252A2 (en) * 2004-10-08 2006-04-20 Potentia Pharmeceuticals, Inc. Viral complement control proteins for eye disorders

Similar Documents

Publication Publication Date Title
Li et al. Development of an antiswelling hydrogel system incorporating M2-exosomes and photothermal effect for diabetic wound healing
Pang et al. An overview of the therapeutic potential of regenerative medicine in cutaneous wound healing
US7183381B2 (en) Composition of lactoferrin related peptides and uses thereof
CN107208107B (zh) 伤口愈合的方法
CN104884076B (zh) 利用了hmgb1片段的心肌梗塞的治疗方法
CN1137723C (zh) 强化的用于加速伤口愈合的伤口覆盖物和组合物
EP2234628B1 (en) Compositions and methods of promoting wound healing
JP2002527401A5 (cg-RX-API-DMAC7.html)
JP2019513689A (ja) 皮膚の創傷、障害、及び疾患を処置するための組成物及び方法
Omata et al. Enhanced bone regeneration by gelatin–β‐tricalcium phosphate composites enabling controlled release of bFGF
Günter et al. New strategies in clinical care of skin wound healing
JP2010155842A5 (cg-RX-API-DMAC7.html)
JP2008526762A5 (cg-RX-API-DMAC7.html)
HRP20090597T1 (hr) Muteini čimbenika rasta fibroblasta 21
JP2014532722A5 (cg-RX-API-DMAC7.html)
Yang et al. Antioxidant-enriched autologous biogel promoted diabetic wound healing by remodeling inherent posttraumatic inflammatory patterning and restoring compromised microenvironment homeostasis
WO2007022537A2 (en) Use of lactoferrin as a chemokine and a chemotactic modulator
JP2015528479A5 (cg-RX-API-DMAC7.html)
JP2008508899A5 (cg-RX-API-DMAC7.html)
MXPA05004074A (es) Nuevos adenovirus, acidos nucleicos que los codifican y su uso.
JP2003189887A5 (cg-RX-API-DMAC7.html)
JP2006296896A (ja) コラーゲン薄膜シート、その製造方法、それを用いた再建方法、および自己組織再生誘導型人工皮膚・粘膜
ES2566344T3 (es) VEGF-A para inducir regeneración del tejido miocárdico
CN109793913A (zh) 包含表皮生长因子的缓释膜敷料
JP2009517343A5 (cg-RX-API-DMAC7.html)